AGN — Argenica Therapeutics Share News
0.000.00%
Last trade - 00:00- AU$14.13m
- AU$9.09m
- AU$0.51m
Brief: Argenica Therapeutics Seeks Trading Halt
Australia's Argenica Therapeutics rises on government grant
Brief: Argenica Therapeutics Awarded A$1.2Mln Crc-P Grant For Tbi Project
Australia's Argenica Therapeutics rises on neuro-protective drug approval
Australia's Argenica jumps on ethics approval to start stroke treatment trial
Australia's Argenica Therapeutics sinks on discounted placement
Brief: Argenica Therapeutics Says It Received Binding Commitments To Raise A$5.5 Mln
Brief: Argenica Therapeutics Seeks Trading Halt
Brief: Argenica Therapeutics Appoints CEO Liz Dallimore Managing Director
Argenica Therapeutics advances on positive data from brain stroke drug study
Brief: Argenica Therapeutics Says Positive Preclincal Data On Efficacy Of Arg-007 In New Indication
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 08:34:41
Australia Stock Exchange release from ARGENICA THERAPE : Peer Reviewed Paper Published on Preclinical Study
Australia Stock Exchange release from ARGENICA THERAPE : Investor Presentation
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 08:35:37
Australia Stock Exchange release from ARGENICA THERAPE : Change of Director's Interest Notice
Australia Stock Exchange release from ARGENICA THERAPE : PRE_NR Ends: 08:20:24
Australia Stock Exchange release from ARGENICA THERAPE : Successful Completion of Final GLP Genotoxicity Studies
Australia Stock Exchange release from ARGENICA THERAPE : Half Yearly Report and Accounts